Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,982

Document Document Title
WO/2020/184142A1
[Problem] To provide a compound which has high stability with respect to heat, high voltage holding ratio if used in a liquid crystal display element, and the like. [Solution] A compound which is represented by formula (1). In the formul...  
WO/2020/178053A1
Phenol derivatives of general formula (I) and (II), wherein meanings of the substituents are indicated in the description, their pharmaceutically acceptable salts, together with the processes for their preparation, their use as antimicro...  
WO/2020/173016A1
The present invention relates to a resorcinol dianisole derivative, wherein the chemical structure of this compound is as represented by the following formula (I). The compound of the present invention can inhibit the binding of programm...  
WO/2020/169770A1
The invention discloses a method for the preparation of fluoro alkylated 1,4-dioxene by homogene- ous Ni catalyzed fluoro alkylation with fluoro alkyl halides of 1,4-dioxane in the presence of a base.  
WO/2020/169768A1
The invention discloses a method for the preparation of fluoro alkylated compounds by homogeneous Ni catalyzed fluoro alkylation with fluoro alkyl halides in the presence of a base.  
WO/2020/166632A1
The present disclosure provides: a method which is capable of producing a fluorolactone compound from hexafluoropropylene oxide or the like by a single step; and the like. The present disclosure relates to a method for producing a comp...  
WO/2020/148619A1
The present invention relates to novel heterocyclic compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers and polymorphs. The invention also relates...  
WO/2020/076274A3
The present invention is related to unique caffeic acid phenethyl ester (CAPE) analogues, methods for preparation of said molecules, and the usage of said unique molecules in the preparation of a pharmaceutical composition that is to be ...  
WO/2019/090085A8
Provided herein are compounds of formula (I), compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions. (Formula I).  
WO/2020/127924A1
The invention relates to a process for the preparation of Voxelotor, or a salt or solvate thereof, which comprises the use of a compound of formula (I) or (I'), or a salt or solvate thereof.  
WO/2020/124433A1
Provided herein is a process for preparing acetals or ketals by reacting Alcohol I, Alcohol II and oxygen in the presence of a metal-organic framework (MOF) catalyst.  
WO/2020/114905A1
According to the present invention a process is provided for producing glycolide which comprises contacting glycolaldehyde dimer with an oxidizing agent to produce a glycolide product.Preferably, the process is carried out in an aprotic ...  
WO/2020/106028A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device comprising same.  
WO/2020/087217A1
The invention relates to a process of preparing a glycolide product from methyl polyglycolate or its product. The process comprises depolymerizing the methyl polyglycolate or its product in the presence of a depolymerization agent to mak...  
WO/2020/087221A1
Provided is a process for producing a product having polyglycolic acid and glycolide from methyl glycolate. The process comprises esterification, polycondensation and optimization. Also provided are a product produced by the process and ...  
WO/2020/087223A1
The invention relates a novel polyglycolic acid. The polyglycolic acid comprises branched repeating units and linear repeating units. The polyglycolic acid may be produced from methyl glycolate by polycondensation in the presence of stru...  
WO/2020/092383A1
The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processe...  
WO/2020/086864A1
Described are positive allosteric modulators of muscarinic acetylcholine receptor M1 (mAChR M1), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating neurological disorders...  
WO/2020/081836A1
The present disclosure provides compounds and compositions capable of extending lifespan, and methods of use thereof.  
WO/2020/064701A1
The present invention generally relates to the formation, chemistry and application of biologically active compositions. More particularly, the present invention relates to certain dyes, specifically porphyrin and chlorin derivatives, in...  
WO/2020/064818A1
Industrially viable and advantageous processes for the preparation of Ozanimod are described. The invention also discloses the intermediates obtained in the process.  
WO/2020/041927A2  
WO/2020/020365A1
The present invention involves a method for isolating, by means of salt formation and resolution, a single optically active N-[(1R,2R)-2-(2,3-dihydro-1,4-benzodioxan-6-yl)-2-hydroxy-1- (1-pyrrolidinylmethyl)ethyl]octanamide as shown in f...  
WO/2020/009132A1
The present invention pertains to a novel method for producing diarylpyridine derivatives, the purpose of the present invention being to provide a industrially useful, novel method. A novel method for synthesizing pyridine rings without ...  
WO/2019/242687A1
The present invention discloses a 1,3-dioxane-4,6-dione compound, and a preparation method, a pharmaceutical composition, and an application thereof. The structure of the compound is represented by formula I, and the definition of each s...  
WO/2019/233474A1
The present disclosure relates to compounds with antiviral activity, methods for the preparation ofsuch compounds, and their use to inhibit viral nucleoprotein activity, viral transcription, replication, and assembly into the newly forme...  
WO/2019/211778A3
The present invention is directed to pro-drugs of Eliglustat (formula A) and process for the preparation thereof. The present invention is further directed to pharmaceutical composition thereof and method of treatment using the same.  
WO/2019/228994A1
This invention relates to oleic acid derivative comprising a hydrophobic part C17H33 linked to a particular polar head part "A", especially for use as a medicament, for instance, for the treatment of a disorder caused by the GPR120 recep...  
WO/2019/219210A1
The present invention relates to a process for producing an intramolecular diester of a hydroxycarboxylic acid, wherein in a first step a hydroxycarboxylic acid is polycondensed to form an oligomeric hydroxycarboxylic acid. This is follo...  
WO/2018/220020A3
The invention relates to resorcinol-derived compounds of formula (I) and also the salts thereof, the solvates thereof and the optical and/or geometrical isomers thereof, including enantiomers and diastereoisomers, the racemic mixtures th...  
WO/2019/185877A1
The invention relates to a method for the preparation of a 4,5-dihydroxyisoleucine derivative comprising the steps of asymmetric Claisen rearrangement of a Z-aminocrotyl-glycin ester and subsequent kinetic resolution of the product diast...  
WO/2019/191445A1
A process for producing a cyclic acetal is disclosed. According to the process, a formaldehyde source is combined with an aprotic compound and contacted with a heterogeneous catalyst which causes the formaldehyde source to convert into a...  
WO/2019/191189A1
The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disor...  
WO/2019/181298A1
This invention addresses the problem of providing a method for producing glycolides, with which glycolides can be produced more rapidly. This method for producing glycolides that solves the problem comprises: an oligomer preparation step...  
WO/2019/181340A1
The purpose of the present invention is to provide a glycolide production method capable of further increasing the rate of production of glycolide. The glycolide production method according to the present invention comprises a step for a...  
WO/2019/181516A1
The purpose of the present invention is to provide a glycolide production method capable of sufficiently increasing the rate of production of glycolide. The glycolide production method according to the present invention comprises a step ...  
WO/2019/173772A1
The present disclosure is directed to l-(2-hydroxy-4-methylcyclohexyl)-ethanone derivatives having unique and desired flavor and/or fragrance characteristics, as well as the synthesis and application of the derivatives. The compounds of ...  
WO/2019/172361A1
According to this method for producing a cyclic ester, a mixture (I) that contains an aliphatic polyester, a specific polyalkylene glycol diether, and a sulfonic acid compound which serves as a thermal stabilizer is prepared and is subse...  
WO/2019/165687A1
A photo-alignment material, a liquid crystal display panel and a preparation method therefor. A chemical structural formula of the photo-alignment material comprises a first group, a second group, a third group, and a fourth group which ...  
WO/2018/140738A8
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, which are activators of nuclear factor erythroid 2 (NF-E2) -related factor 2 (Nrf2) and are useful to treat diseases caused by oxidative stress, such as n...  
WO/2019/151384A1
One embodiment of the present invention relates to novel substances, etc., which are: [1] a compound, etc., represented by formula (A1) or formula (B1); [2] a compound, etc., represented by formula (A2) or formula (B2); [3] a compound, e...  
WO/2019/145719A1
The present invention relates to compounds of Formula I as defined herein, and salts and solvates thereof. (I) The present invention also relates to pharmaceutical compositions comprising compounds of Formula (I), and to compounds of For...  
WO/2019/145718A1
The present invention relates to compounds of Formula I as defined herein, and salts and solvates thereof. (I) The present invention also relates to pharmaceutical compositions comprising compounds of Formula(I), and to compounds of Form...  
WO/2019/128918A1
Disclosed in the present invention are an aromatic vinyl or aromatic ethyl derivative, a preparation method therefor, an intermediate, a pharmaceutical composition, and an application. The aromatic vinyl or aromatic ethyl derivative in t...  
WO/2019/120101A1
Disclosed is a compound having the structure of formula I. Also disclosed is a liquid crystal composition comprising the compound of formula I, and a photoelectric display component comprising the liquid crystal composition. The compound...  
WO/2019/124092A1
The present invention provides: a compound represented by formula (i), a liquid crystal composition using said compound, and a liquid crystal display device using said liquid crystal composition. The compound represented by formula (i) h...  
WO/2019/123476A1
The present invention relates to pharmaceutical compositions of Eliglustat. In particular the present invention relates to stable amorphous Eliglustat premix having enhanced stability and dissolution properties. The present invention als...  
WO/2019/124345A1
The present invention addresses the problem of providing: a polymerizable liquid crystal composition that satisfies the demand for the high-speed response, low-voltage drive, high contrast, long-term reliability, and the like that have h...  
WO/2019/108033A1
The present specification provides a compound represented by chemical formula 1, and an organic light emitting element comprising the same.  
WO/2019/101059A1
A compound having the structure shown in formula I, a liquid crystal composition comprising the compound having the structure shown in formula I, and an electro-optical display device comprising the liquid crystal composition. The compou...  

Matches 1 - 50 out of 7,982